Professor in Neurology, Physiology, and Psychiatry; Founder & Executive Director of Neuroscape
Dr. Gazzaley is a Professor of Neurology, Physiology, and Psychiatry, and the founder of Neuroscape. Dr. Gazzaley designs and develops novel brain assessments and therapies, like therapeutic video games, that focus on attention disorders.
Dr. Adam Gazzaley is a Professor in Neurology, Physiology, and Psychiatry at the University of California San Francisco, and the Founder & Executive Director of Neuroscape.
Neuroscape is a translational neuroscience center engaged in technology creation and scientific research. Dr. Gazzaley designs and develops novel brain assessment and optimization tools to impact education, wellness, and medical practices.
Dr. Gazzaley is also the co-founder and Chief Science Advisor of Akili Interactive Labs, a company developing therapeutic video games, and co-founder and Chief Scientist of JAZZ Venture Partners, a venture capital firm investing in experiential technology to improve human performance. In addition, he is a scientific advisor for over a dozen technology companies including Apple, GE, Magic Leap, and The VOID, and on the Science Board of the President’s Council on Fitness, Sports & Nutrition.
Dr. Gazzaley has filed multiple patents for his inventions, authored over 125 scientific articles, and delivered over 540 invited presentations around the world. His research and perspectives have been consistently profiled in high-impact media, such as The New York Times, New York Times Magazine, New Yorker, Wall Street Journal, TIME, Discover, Wired, PBS, NPR, CNN, and NBC Nightly News. He wrote and hosted the nationally-televised PBS special “The Distracted Mind with Dr. Adam Gazzaley”, and co-authored the 2016 MIT Press book “The Distracted Mind: Ancient Brains in a High-Tech World”, winner of the 2017 PROSE Award in the category of Biomedicine and Neuroscience.
Dr. Gazzaley has received many awards and honors, including the 2015 Society for Neuroscience – Science Educator Award.
Education and Training
Binghamton University – Biochemistry (1990)
MD + PhD
Mount Sinai School of Medicine, Neuroscience (1998)
Mount Sinai School of Medicine
Internship and Residency
Hospital of the University of Pennsylvania, Cal Berkeley, UCSF
AB of Psychiatry & Neurology, Psychiatry (2004)
“AIM is positioning itself to help with the critical and growing crisis in addressing challenges of attention and emotional regulation experienced by our children. The need is great and this could not happen soon enough from my perspective.”Adam GazzaleyUCSF